Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)

Leukemia. 2002 Sep;16(9):1888. doi: 10.1038/sj.leu.2402616.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / chemically induced*
  • Leukemia, Myeloid, Acute / therapy
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / pathology
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Myelodysplastic Syndromes / chemically induced*
  • Myelodysplastic Syndromes / therapy
  • Neoplasms, Second Primary / chemically induced*
  • Prednisone / administration & dosage
  • Remission Induction
  • Tretinoin / therapeutic use
  • Vincristine / administration & dosage

Substances

  • Antineoplastic Agents
  • Tretinoin
  • Vincristine
  • Mercaptopurine
  • Prednisone
  • Methotrexate

Supplementary concepts

  • POMP protocol